ORLANDO, Fla.--(BUSINESS WIRE)--GeneLink, Inc. (OTCBB:GNLK.OB), a leading consumer genomics biotech company, announced today that it has received official notice from the Australian Patent Office that the patent claims set forth in its application for "Kits and Methods for Assessing Skin Health" (Australian Application No. 2003275038) are in condition for allowance. This is the fourth patent to be granted from a family of applications filed by GeneLink in the U.S. and abroad.
